Lanreotide
Product Description
Aspen Healthcare. We Care
-
Country/Region:Netherlands
-
On CPHI since:2015
-
Certificates:4
-
Employees:5000+
Company types
Primary activities
Categories
Specifications
Aspen Healthcare. We Care
-
Country/Region:Netherlands
-
On CPHI since:2015
-
Certificates:4
-
Employees:5000+
Company types
Primary activities
More Products from Aspen Healthcare. We Care (58)
-
Product Thioridazine Hydrochloride
This API is part of the FCC product portfolio -
Product Thiothixene
This API is part of the FCC product portfolio -
Product Vinblastine Sulfate
This API is part of the FCC product portfolio -
Product Vincristine Sulfate
This API is part of the FCC product portfolio -
Product Segesterone acetate
Under development - samples are available -
Product Sugammadex
Commercially available -
Product Morphine Sulfate
This API is part of the FCC product portfolio and is available for selected markets only -
Product Morphine Tartrate
This API is part of the FCC product portfolio and is available for selected markets only -
Product Morphine Hydrochloride
This API is part of the FCC product portfolio and is available for selected markets only -
Product Fentanyl citrate
This API is part of the FCC product portfolio and is available for selected markets only
Aspen Healthcare. We Care resources (5)
-
Sponsored Content Aspen API’s Green answer to peptide synthesis
Our Green Continuous Liquid Phase Peptide Synthesis (GC-LPPS) combines the advantages of the classical solution-phase synthesis with the solid-phase approach.
-
Brochure Aspen. Healthcare. We Care.
Aspen is a global specialty and branded pharmaceutical company committed to promoting access to medicines and improving the health of patients across the world through our high quality, affordable products. Active at every stage of the value chain, we are uniquely diversified by geography, product and manufacturing capability. -
News CPHI Trend Report - Sustainability in Pharma
While in the past, much of the discussion around sustainability in the pharmaceutical industry rightly focused on efforts to minimize the environmental impact of drug production, the needle has now shifted. There are signs that companies not only understand that it represents one of the world’s biggest challenges moving forward, but also that they are starting to incorporate sustainability practices into a much broader suite of operations.
